Article Text


Medical termination of pregnancy in the early first trimester
  1. Haitham Hamoda, MRCOG, Clinical Research Fellow and
  2. Gillian M M Flett, FRCOG, Consultant in Family Planning and Reproductive Health
  1. Department of Obstetrics and Gynaecology, University of Aberdeen, Aberdeen, UK
  1. Correspondence to Dr H Hamoda, Department of Obstetrics and Gynaecology, University of Aberdeen, Aberdeen Maternity Hospital, Foresterhill, Cornhill Road, Aberdeen AB25 2ZD, UK. Tel: +44 (0) 1224 553582. Fax: +44 (0) 1224 684880. E-mail: ogy262{at}


Surgical abortion using vacuum aspiration or dilatation and curettage has been the method of choice for termination of pregnancy up to 63 days' gestation since the 1960s. Over the last three decades many studies have explored the use of medical methods for inducing abortion at these gestations. Earlier regimens assessed the systemic and intrauterine injection of prostaglandins. This was followed in the 1980s by the introduction of the antiprogesterone, mifepristone. Since its introduction, the uptake of medical abortion has been steadily increasing in countries where it has been available for routine use. Most current clinical protocols require the use of prostaglandins in combination with anti-progesterones or antimetabolites. The safety, efficacy and acceptability of the medical regimen are now well established at all gestations of pregnancy. Provision of medical abortion increases the choice available to women, in particular those wishing to avoid surgery.

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.